TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35918278

Group type: EXPERIMENTAL
Intervention: Supervised surgical procedure
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unsupervised surgical procedure
Number of subjects: 20
Study: 33538030

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (preservative free morphine sulfate, 0.09 mg/kg; 1% ropivacaine, 0.2 mg/kg; total volume delivered, 1 mL/4.5 kg of body weight to a maximum of 10 mL; n = 9)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Nonepidural control (n = 13)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 26
Study: 32541328

Group type: EXPERIMENTAL
Intervention: mFOLFOX regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy
Number of subjects: 0
Study: 35230585

Group type: EXPERIMENTAL
Intervention: FEC-100 (6 cycles of 5-FU, epirubicin, and cyclophosphamide)
Number of subjects: 2722

Group type: COMPARATOR
Intervention: AC (4 cycles of doxorubicin and cyclophosphamide)
Number of subjects: 2722

Group type: EXPERIMENTAL
Intervention: FEC-100
Number of subjects: 2722
Study: 32171875

Group type: COMPARATOR
Intervention: Conventional root canal therapy (Group I)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Conventional root canal therapy combined with antimicrobial PDT (Group II)
Number of subjects: 30
Study: 36241464

Group type: EXPERIMENTAL
Intervention: ProTaper Next
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fanta AF baby
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Kidzo Elephant
Number of subjects: 18
Study: 33404083

Group type: EXPERIMENTAL
Intervention: Comprehensive school physical activity and healthy eating program
Number of subjects: 628

Group type: COMPARATOR
Intervention: Comparison group (no specific intervention mentioned)
Number of subjects: 628
Study: 33610421

Group type: EXPERIMENTAL
Intervention: L-arginine (3 gr/d for 10 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32456618

Group type: EXPERIMENTAL
Intervention: Mobile SMS counselling intervention
Number of subjects: 384
Study: 33930939

Group type: EXPERIMENTAL
Intervention: PMA-zeolite
Number of subjects: 41

Group type: COMPARATOR
Intervention: Microcrystalline cellulose (control)
Number of subjects: 41
Study: 35948699

Group type: EXPERIMENTAL
Intervention: LLLT with nimesulide (N-P group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nimesulide alone
Number of subjects: 40

Group type: COMPARATOR
Intervention: LLLT alone
Number of subjects: 40
Study: 33540223

Group type: EXPERIMENTAL
Intervention: Group-based mind-body physical activity intervention with Fitbit (GetActive-Fitbit; n = 41)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Group-based mind-body physical activity intervention without Fitbit (GetActive; n = 41)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Both interventions (GetActive-Fitbit and GetActive)
Number of subjects: 82
Study: 32282100

Group type: EXPERIMENTAL
Intervention: Vyxeos (daunorubicin-cytarabine) liposome injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard 3+7 daunorubicin and cytarabine
Number of subjects: 0
Study: 36294856

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB) using 20 mL of 0.5% ropivacaine bilaterally
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no ESPB)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 59
Study: 33385980

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1248

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1248

Group type: COMPARATOR
Intervention: Medical therapy (MT) alone
Number of subjects: 1248
Study: 35649656

Group type: EXPERIMENTAL
Intervention: Simple calculation and reading aloud
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34384638

Group type: EXPERIMENTAL
Intervention: 3-strand round twisted (RT) retainer
Number of subjects: 133

Group type: COMPARATOR
Intervention: 8-strand rectangular braided (RB) retainer
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Both RT and RB retainers
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Periodontal parameters (periodontal index, bleeding on probing, plaque index, gingival index, probing depth)
Number of subjects: 133
Study: 32160765

Group type: EXPERIMENTAL
Intervention: Left prefrontal transcranial magnetic stimulation (TMS) targeting specific brain circuits for dysphoric symptoms (sadness and anhedonia)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Left prefrontal transcranial magnetic stimulation (TMS) targeting specific brain circuits for anxiety and somatic symptoms
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Active TMS stimulation
Number of subjects: 198

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 198
Study: 35227659

Group type: EXPERIMENTAL
Intervention: Developed equation using BMI, age, and sex
Number of subjects: 107

Group type: COMPARATOR
Intervention: Deurenberg equation
Number of subjects: 107
Study: 33076952

Group type: EXPERIMENTAL
Intervention: Active‐assistive robotic intervention (ACT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Passive robotic intervention (PSV)
Number of subjects: 20
Study: 35244061

Group type: EXPERIMENTAL
Intervention: Bojungikgi-tang (BJT) granules administered twice a day for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (no BJT granules)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: BJT
Number of subjects: 40
Study: 33029527

Group type: EXPERIMENTAL
Intervention: Ultrasound trainee
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Radiology trainee
Number of subjects: 35

Group type: COMPARATOR
Intervention: Trainees vs. laparoscopy/histology
Number of subjects: 35
Study: 35771533

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula/long-term oxygen therapy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Long-term oxygen therapy
Number of subjects: 104
Study: 34253233

Group type: EXPERIMENTAL
Intervention: 5-ALA HCl 15 mg/kg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 5-ALA HCl 30 mg/kg
Number of subjects: 54

Group type: COMPARATOR
Intervention: No 5-ALA
Number of subjects: 54
Study: 35532732

Group type: EXPERIMENTAL
Intervention: MED-WELL programme (exercise intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MBSR programme (control)
Number of subjects: 0
Study: 33593066

Group type: EXPERIMENTAL
Intervention: Automated workflow for rational construction of plasmids and their conjugative transfer into Corynebacterium glutamicum
Number of subjects: 0
Study: 32803636

Group type: EXPERIMENTAL
Intervention: Green tea supplements (1 g twice daily; containing 300 mg EGCG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen monotherapy
Number of subjects: 0
Study: 33822033

Group type: EXPERIMENTAL
Intervention: Spironolactone (25-50 mg/day)
Number of subjects: 527

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 527
Study: 32355067

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 1443

Group type: EXPERIMENTAL
Intervention: Clopidogrel (in diabetic patients)
Number of subjects: 1443
Study: 34085581

Group type: EXPERIMENTAL
Intervention: Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32650682

Group type: EXPERIMENTAL
Intervention: Cartilage push-through technique
Number of subjects: 93

Group type: COMPARATOR
Intervention: Underlay fascia graft technique
Number of subjects: 93
Study: 34120525

Group type: EXPERIMENTAL
Intervention: Manager-targeted educational intervention (3-hour seminar)
Number of subjects: 915
Study: 33831981

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no OMT)
Number of subjects: 26
Study: 33303428

Group type: EXPERIMENTAL
Intervention: Manual therapy (1 to 3 sessions at intervals of one per week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroid injections (1 mL of Diprostène via ultrasound-guided injection)
Number of subjects: 0
Study: 35041046

Group type: EXPERIMENTAL
Intervention: Extruded rice snacks containing 400 mg DHA from cauliflower-encapsulated HiDHA® algal oil
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Soup containing 400 mg DHA from cauliflower-encapsulated HiDHA® algal oil
Number of subjects: 27

Group type: COMPARATOR
Intervention: Gel capsules containing HiDHA® algal oil
Number of subjects: 27
Study: 35838817

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise (BDJ)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Brisk walking (BWK)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Usual physical activity (UPA)
Number of subjects: 135
Study: 33046619

Group type: EXPERIMENTAL
Intervention: Mexiletine (150 mg 3 times daily)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 36464571

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) for 20 min
Number of subjects: 105

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 105
Study: 34148351

Group type: EXPERIMENTAL
Intervention: Apixaban or rivaroxaban (direct acting oral anticoagulation)
Number of subjects: 1421
Study: 32957929

Group type: COMPARATOR
Intervention: Sufentanil plasma target concentration 0.0 ng ml-1 (Group S0)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Sufentanil plasma target concentration 0.1 ng ml-1 (Group S1)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Sufentanil plasma target concentration 0.3 ng ml-1 (Group S2)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Sufentanil plasma target concentration 0.5 ng ml-1 (Group S3)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Sufentanil plasma target concentration 0.7 ng ml-1 (Group S4)
Number of subjects: 85
Study: 36159012

Group type: EXPERIMENTAL
Intervention: Radiomics signature, alpha-fetoprotein (AFP), neutrophil-to-lymphocyte ratio (NLR)
Number of subjects: 150
Study: 32229523

Group type: EXPERIMENTAL
Intervention: Accelerated partner therapy (APT)
Number of subjects: 5440

Group type: COMPARATOR
Intervention: Standard partner notification (PN)
Number of subjects: 5440
Study: 33371995

Group type: EXPERIMENTAL
Intervention: Nurse Administered Propofol Sedation (NAPS)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Moderate midazolam and fentanyl sedation
Number of subjects: 130
Study: 35994347

Group type: EXPERIMENTAL
Intervention: Active washing filtration system (Revolve system)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Passive washing filtration system (Puregraft system)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Centrifugation (Coleman technique)
Number of subjects: 46

Group type: COMPARATOR
Intervention: All groups (comparison)
Number of subjects: 46
Study: 33190147

Group type: EXPERIMENTAL
Intervention: Omega-3 carboxylic acid (4 g/d)
Number of subjects: 13078

Group type: COMPARATOR
Intervention: Corn oil (inert comparator)
Number of subjects: 13078
Study: 35597286

Group type: EXPERIMENTAL
Intervention: Smartphone-guided self-prone positioning
Number of subjects: 293

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 293
Study: 34535694

Group type: EXPERIMENTAL
Intervention: Genetic risk score (GRS) 50
Number of subjects: 12120

Group type: EXPERIMENTAL
Intervention: Genetic risk score (GRS) 27
Number of subjects: 12120

Group type: EXPERIMENTAL
Intervention: Algorithms including paternal information and GRS
Number of subjects: 12120

Group type: COMPARATOR
Intervention: Algorithms including GRS only
Number of subjects: 12120
Study: 33603939

Group type: EXPERIMENTAL
Intervention: 20 mL of 0.375% ropivacaine with 100 ng of naloxone
Number of subjects: 74

Group type: COMPARATOR
Intervention: 20 mL of 0.375% ropivacaine
Number of subjects: 74
Study: 33187170

Group type: EXPERIMENTAL
Intervention: Unhealthy lifestyle (poor diet, lower intensity of physical exercise, higher alcohol intake, smoking)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Sociodemographic factors (being older, in a relationship, and employed)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Risky sexual behaviors (lower use of condoms, higher frequency of risky sexual behaviors)
Number of subjects: 335
Study: 34652445

Group type: EXPERIMENTAL
Intervention: β-lactam (amoxicillin-clavulanate [1 g/125 mg] 3 times daily) for 5 extra days
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo for 5 extra days
Number of subjects: 291
Study: 34252001

Group type: EXPERIMENTAL
Intervention: 2 repetitions of 20m sprint accelerations (S)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3x10 alternative leg weighted bounding (P)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 0
Study: 32305106

Group type: EXPERIMENTAL
Intervention: 1 g TXA
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35361168

Group type: EXPERIMENTAL
Intervention: MULTI +
Number of subjects: 0

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 0
Study: 33685237

Group type: EXPERIMENTAL
Intervention: Pulsed high-intensity laser therapy (HILT)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (EMF)
Number of subjects: 51
Study: 32799792

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.5 mg/kg intravenously
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups (KT and control)
Number of subjects: 90
Study: 34656072

Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Esomeprazole with cola
Number of subjects: 22
Study: 33876306

Group type: EXPERIMENTAL
Intervention: High tie (HT) vascular ligation
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Low tie (LT) vascular ligation
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Low tie plus lymph node dissection (LT-appic LND)
Number of subjects: 208
Study: 33707982

Group type: EXPERIMENTAL
Intervention: Stretching (30s × 1 set)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Stretching (30s × 3 repetitions)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Long duration stretching (30s × 10 sets)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Short duration stretching (30s × 1 set)
Number of subjects: 36
Study: 33512943

Group type: EXPERIMENTAL
Intervention: 3 sessions of radial extracorporeal shockwave therapy (rESWT) at the 'recommended'/'maximally comfortably tolerated' dose
Number of subjects: 120

Group type: COMPARATOR
Intervention: 3 sessions of radial extracorporeal shockwave therapy (rESWT) at 'minimal dose'
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (recommended dose and minimal dose)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 3 sessions of rESWT (both doses)
Number of subjects: 120
Study: 34158017

Group type: EXPERIMENTAL
Intervention: Psychotherapeutic consultation at work (up to 17 sessions of psychotherapy, including work-related diagnostics and consultations)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Cost-benefit assessment related to costs of common mental disorders for social insurances and companies
Number of subjects: 520
Study: 35510753

Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL) combined with minocycline (100 mg per day for 8 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Minocycline only (100 mg per day for 8 weeks)
Number of subjects: 40
Study: 32146687

Group type: EXPERIMENTAL
Intervention: Barbed sutures
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-of-care sutures
Number of subjects: 60
Study: 36072252

Group type: EXPERIMENTAL
Intervention: Scrambler Therapy (ST)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (pain management drugs following the WHO analgesic ladder)
Number of subjects: 80
Study: 33947448

Group type: EXPERIMENTAL
Intervention: Automated audit and feedback intervention delivered electronically 4 times over 12 months.
Number of subjects: 0
Study: 33120777

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with antidepressants
Number of subjects: 60

Group type: COMPARATOR
Intervention: Antidepressants only (Control)
Number of subjects: 60
Study: 35578544

Group type: EXPERIMENTAL
Intervention: Store-and-forward teledermatology system
Number of subjects: 388

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 388
Study: 33694206

Group type: EXPERIMENTAL
Intervention: Tailored-Ablation Index (TAI) protocol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Force-Time Integral (FTI) protocol
Number of subjects: 100
Study: 32645161

Group type: EXPERIMENTAL
Intervention: Statin as a cardiovascular disease prevention strategy
Number of subjects: 7770
Study: 33721562

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg intravenously every 3 weeks
Number of subjects: 304

Group type: COMPARATOR
Intervention: Brentuximab vedotin 1.8 mg/kg intravenously every 3 weeks
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 304

Group type: COMPARATOR
Intervention: Brentuximab vedotin
Number of subjects: 304
Study: 34261908

Group type: EXPERIMENTAL
Intervention: Short-course antibiotic therapy (7 days or less) after removal of the central venous catheter (CVC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-course antibiotic therapy (7-14 days)
Number of subjects: 0
Study: 32269083

Group type: EXPERIMENTAL
Intervention: Loneliness (measured using a 6-item Loneliness Scale for Emotional and Social Loneliness)
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Self-rated physical health (assessed as poor, fair, good, very good, or excellent)
Number of subjects: 770

Group type: COMPARATOR
Intervention: Self-rated physical health (poor/fair)
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Loneliness
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Depressive symptomatology
Number of subjects: 770
Study: 36369798

Group type: EXPERIMENTAL
Intervention: Deucravacitinib 3 mg twice daily
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Deucravacitinib 6 mg twice daily
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Deucravacitinib 12 mg once daily
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Deucravacitinib (all doses)
Number of subjects: 363
Study: 35714812

Group type: EXPERIMENTAL
Intervention: GSK3389404 (60 mg weekly)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: GSK3389404 (120 mg weekly)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: GSK3389404 (120 mg bi-weekly)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: GSK3389404
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: GSK3389404 (120 mg weekly, 120 mg bi-weekly)
Number of subjects: 66
Study: 33380248

Group type: EXPERIMENTAL
Intervention: IV Methylprednisolone
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: IV Hydrocortisone
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: IV Dexamethasone
Number of subjects: 61
Study: 34553379

Group type: EXPERIMENTAL
Intervention: Re:MIX program cofacilitated by professional health educators and young parent educators
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study: 32932891

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection of Botulinum Toxin Type A (24 U)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional blind injection of Botulinum Toxin Type A (24 U)
Number of subjects: 20
Study: 34209804

Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus paracasei strain Shirota (LcS) beverage (100 mL, 108 CFU/mL)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus paracasei strain Shirota (LcS) beverage
Number of subjects: 82
Study: 35952529

Group type: EXPERIMENTAL
Intervention: Dexamethasone IV combined with 15 sessions of hyperbaric oxygen therapy (SS + HBOT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dexamethasone IV (SS)
Number of subjects: 50
Study: 34355814

Group type: EXPERIMENTAL
Intervention: rhIGF-1/Risedronate
Number of subjects: 90

Group type: COMPARATOR
Intervention: Risedronate
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 32601949

Group type: EXPERIMENTAL
Intervention: CT-based radiomics model
Number of subjects: 145
Study: 36513488

Group type: EXPERIMENTAL
Intervention: 15-min dough kneading time (K15)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 10-min dough kneading time (K10)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Coarse flour (CF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fine flour (FF)
Number of subjects: 10
Study: 33893799

Group type: EXPERIMENTAL
Intervention: BCG vaccination + oral polio vaccine (OPV) immediately upon admission
Number of subjects: 3353

Group type: COMPARATOR
Intervention: BCG vaccination + OPV at hospital discharge (control)
Number of subjects: 3353

Group type: EXPERIMENTAL
Intervention: BCG vaccination + OPV immediately upon admission
Number of subjects: 3353
Study: 34973048

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Applied Relaxation (AR)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Both treatments (PE and AR)
Number of subjects: 98
Study: 36316847

Group type: EXPERIMENTAL
Intervention: NRT + AA
Number of subjects: 40

Group type: COMPARATOR
Intervention: NRT
Number of subjects: 40
Study: 32339320

Group type: EXPERIMENTAL
Intervention: Microsurgical subinguinal varicocelectomy with testicular delivery (TD)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Microsurgical subinguinal varicocelectomy without testicular delivery (TD)
Number of subjects: 181
Study: 35553185

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 32093772

Group type: EXPERIMENTAL
Intervention: A-FFIP
Number of subjects: 134

Group type: COMPARATOR
Intervention: EIAU
Number of subjects: 134
Study: 34632490

Group type: EXPERIMENTAL
Intervention: Furosemide 80 mg bolus
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study: 35866691

Group type: EXPERIMENTAL
Intervention: Propes and Inflamafertin
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control (no immunotherapy)
Number of subjects: 212